Computed Tomography Perfusion After Thrombectomy: An Immediate Surrogate Marker of Outcome After Recanalization in Acute Stroke.


Journal

Stroke
ISSN: 1524-4628
Titre abrégé: Stroke
Pays: United States
ID NLM: 0235266

Informations de publication

Date de publication:
06 2020
Historique:
pubmed: 15 5 2020
medline: 15 9 2020
entrez: 15 5 2020
Statut: ppublish

Résumé

Background and Purpose- Despite recanalization, almost 50% of patients undergoing endovascular treatment (EVT) experience poor outcome. We aim to evaluate the value of computed tomography perfusion as immediate outcome predictor postendovascular treatment. Methods- Consecutive patients receiving endovascular treatment who achieved recanalization (modified Thrombolysis in Cerebral Ischemia [mTICI] 2a-3) underwent computed tomography perfusion within 30 minutes from recanalization (CTPpost). Hypoperfusion was defined as the Tmax>6 second volume; hyperperfusion as visually increased cerebral blood flow/cerebral blood volume with reduced Tmax compared with unaffected hemisphere. Dramatic clinical recovery (DCR) was defined as 24-hour National Institutes of Health Stroke Scale score ≤2 or ≥8 points drop. Delayed recovery was defined as no-DCR with favorable outcome (modified Rankin Scale score 0-2) at 3 months. Results- We included 151 patients: median National Institutes of Health Stroke Scale score 16 (interquartile range, 10-21), median admission ASPECTS 9 (interquartile range, 8-10). Final recanalization was the following: mTICI2a 11 (7.3%), mTICI2b 46 (30.5%), and mTICI3 94 (62.3%). On CTPpost, 80 (52.9%) patients showed hypoperfusion (median Tmax>6 seconds: 4 cc [0-25]) and 32 (21.2%) hyperperfusion. There was an association between final TICI and CTPpost hypoperfusion(median Tmax>6: 91 [56-117], 15 [0-37.5], and 0 [0-7] cc, for mTICI 2a, 2b, and 3, respectively,

Identifiants

pubmed: 32404034
doi: 10.1161/STROKEAHA.120.029212
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1736-1742

Auteurs

Marta Rubiera (M)

From the Stroke Unit, Department of Neurology (M. Rubiera, A.G.-T., M.O.-G., D.C., M. Requena, J.P., D.R.-L., M.M., S.B., N.R.-V., J.J., M.D., E.S., C.A.M., M. Ribo), Hospital Vall d'Hebron, Departament de Medicina, Universitat Autònoma de Barcelona.

Alvaro Garcia-Tornel (A)

From the Stroke Unit, Department of Neurology (M. Rubiera, A.G.-T., M.O.-G., D.C., M. Requena, J.P., D.R.-L., M.M., S.B., N.R.-V., J.J., M.D., E.S., C.A.M., M. Ribo), Hospital Vall d'Hebron, Departament de Medicina, Universitat Autònoma de Barcelona.

Marta Olivé-Gadea (M)

From the Stroke Unit, Department of Neurology (M. Rubiera, A.G.-T., M.O.-G., D.C., M. Requena, J.P., D.R.-L., M.M., S.B., N.R.-V., J.J., M.D., E.S., C.A.M., M. Ribo), Hospital Vall d'Hebron, Departament de Medicina, Universitat Autònoma de Barcelona.

Daniel Campos (D)

From the Stroke Unit, Department of Neurology (M. Rubiera, A.G.-T., M.O.-G., D.C., M. Requena, J.P., D.R.-L., M.M., S.B., N.R.-V., J.J., M.D., E.S., C.A.M., M. Ribo), Hospital Vall d'Hebron, Departament de Medicina, Universitat Autònoma de Barcelona.

Manuel Requena (M)

From the Stroke Unit, Department of Neurology (M. Rubiera, A.G.-T., M.O.-G., D.C., M. Requena, J.P., D.R.-L., M.M., S.B., N.R.-V., J.J., M.D., E.S., C.A.M., M. Ribo), Hospital Vall d'Hebron, Departament de Medicina, Universitat Autònoma de Barcelona.

Carla Vert (C)

Department of Neurorradiology (C.V., D.H., C.P., A.T.), Hospital Vall d'Hebron, Departament de Medicina, Universitat Autònoma de Barcelona.

Jorge Pagola (J)

From the Stroke Unit, Department of Neurology (M. Rubiera, A.G.-T., M.O.-G., D.C., M. Requena, J.P., D.R.-L., M.M., S.B., N.R.-V., J.J., M.D., E.S., C.A.M., M. Ribo), Hospital Vall d'Hebron, Departament de Medicina, Universitat Autònoma de Barcelona.

David Rodriguez-Luna (D)

From the Stroke Unit, Department of Neurology (M. Rubiera, A.G.-T., M.O.-G., D.C., M. Requena, J.P., D.R.-L., M.M., S.B., N.R.-V., J.J., M.D., E.S., C.A.M., M. Ribo), Hospital Vall d'Hebron, Departament de Medicina, Universitat Autònoma de Barcelona.

Marian Muchada (M)

From the Stroke Unit, Department of Neurology (M. Rubiera, A.G.-T., M.O.-G., D.C., M. Requena, J.P., D.R.-L., M.M., S.B., N.R.-V., J.J., M.D., E.S., C.A.M., M. Ribo), Hospital Vall d'Hebron, Departament de Medicina, Universitat Autònoma de Barcelona.

Sandra Boned (S)

From the Stroke Unit, Department of Neurology (M. Rubiera, A.G.-T., M.O.-G., D.C., M. Requena, J.P., D.R.-L., M.M., S.B., N.R.-V., J.J., M.D., E.S., C.A.M., M. Ribo), Hospital Vall d'Hebron, Departament de Medicina, Universitat Autònoma de Barcelona.

Noelia Rodriguez-Villatoro (N)

From the Stroke Unit, Department of Neurology (M. Rubiera, A.G.-T., M.O.-G., D.C., M. Requena, J.P., D.R.-L., M.M., S.B., N.R.-V., J.J., M.D., E.S., C.A.M., M. Ribo), Hospital Vall d'Hebron, Departament de Medicina, Universitat Autònoma de Barcelona.

Jesus Juega (J)

From the Stroke Unit, Department of Neurology (M. Rubiera, A.G.-T., M.O.-G., D.C., M. Requena, J.P., D.R.-L., M.M., S.B., N.R.-V., J.J., M.D., E.S., C.A.M., M. Ribo), Hospital Vall d'Hebron, Departament de Medicina, Universitat Autònoma de Barcelona.

Matias Deck (M)

From the Stroke Unit, Department of Neurology (M. Rubiera, A.G.-T., M.O.-G., D.C., M. Requena, J.P., D.R.-L., M.M., S.B., N.R.-V., J.J., M.D., E.S., C.A.M., M. Ribo), Hospital Vall d'Hebron, Departament de Medicina, Universitat Autònoma de Barcelona.

Estela Sanjuan (E)

From the Stroke Unit, Department of Neurology (M. Rubiera, A.G.-T., M.O.-G., D.C., M. Requena, J.P., D.R.-L., M.M., S.B., N.R.-V., J.J., M.D., E.S., C.A.M., M. Ribo), Hospital Vall d'Hebron, Departament de Medicina, Universitat Autònoma de Barcelona.

David Hernandez (D)

Department of Neurorradiology (C.V., D.H., C.P., A.T.), Hospital Vall d'Hebron, Departament de Medicina, Universitat Autònoma de Barcelona.

Carlos Piñana (C)

Department of Neurorradiology (C.V., D.H., C.P., A.T.), Hospital Vall d'Hebron, Departament de Medicina, Universitat Autònoma de Barcelona.

Alejandro Tomasello (A)

Department of Neurorradiology (C.V., D.H., C.P., A.T.), Hospital Vall d'Hebron, Departament de Medicina, Universitat Autònoma de Barcelona.

Carlos A Molina (CA)

From the Stroke Unit, Department of Neurology (M. Rubiera, A.G.-T., M.O.-G., D.C., M. Requena, J.P., D.R.-L., M.M., S.B., N.R.-V., J.J., M.D., E.S., C.A.M., M. Ribo), Hospital Vall d'Hebron, Departament de Medicina, Universitat Autònoma de Barcelona.

Marc Ribo (M)

From the Stroke Unit, Department of Neurology (M. Rubiera, A.G.-T., M.O.-G., D.C., M. Requena, J.P., D.R.-L., M.M., S.B., N.R.-V., J.J., M.D., E.S., C.A.M., M. Ribo), Hospital Vall d'Hebron, Departament de Medicina, Universitat Autònoma de Barcelona.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH